ESR1 and liver cancer: In addition, in E2-sensitive cancer cells (e.g., breast and liver cancers), a progressive increase of ERα amount and a parallel decrease of ERβ expression have been reported.7 Remarkably, ERα genomic and membrane starting signal transduction pathways cooperatively work to achieve cancer cell proliferation and apoptotic cascade prevention.1,8, 9, 10